Company Filing History:
Years Active: 2019
Title: The Innovative Mind of Tohru Amemiya
Introduction
Tohru Amemiya, an accomplished inventor based in Shizuoka Prefecture, Japan, has made significant contributions to the field of pharmaceutical formulations. His work primarily focuses on the development of innovative capsular dosage forms that utilize polyunsaturated free fatty acids, showcasing his commitment to advancing medical science.
Latest Patents
Amemiya holds a key patent entitled "Millicapsule formulations comprising polyunsaturated free fatty acids." This patent describes capsular dosage forms containing unique polyunsaturated fatty acid (PUFA) compositions. The invention offers a unit dosage form comprising multiple millicapsules filled with a PUFA composition, enhancing the delivery and effectiveness of these essential fatty acids in pharmaceutical applications. Notably, in certain embodiments, this formulation includes Epanova® as the PUFA composition, highlighting its potential impact on health and wellness.
Career Highlights
During his career at Omthera Pharmaceuticals Inc., Tohru Amemiya has distinguished himself as a leader in the development of innovative drug delivery systems. His work exemplifies the intersection of science and practical application, as he pushes the boundaries of what is possible in pharmaceutical formulations. His patent enables new possibilities for patients requiring targeted fatty acid therapies, marking a significant milestone in pharmaceutical innovation.
Collaborations
Amemiya collaborates closely with esteemed colleagues, including Hironori Kubota and Etienne Thierry Charles Rogeau. These partnerships are integral to driving forward the research and development processes at Omthera Pharmaceuticals, allowing for multidisciplinary approaches that enhance the efficacy of their medicinal products.
Conclusion
Tohru Amemiya's inventive spirit and dedication to pharmaceutical advancement have positioned him as a prominent figure in the field. His patent on millicapsule formulations not only contributes to the scientific community but also holds the potential to make a meaningful difference in the lives of patients. As the industry continues to evolve, innovators like Amemiya will undoubtedly play a crucial role in shaping the future of medicine.